NCT07535736Not yet recruiting
Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury
Role of Prophylactic Anti-epileptic Regimen in Traumatic Brain Injury
Source: ClinicalTrials.gov · Last updated 17 Apr 2026
Brief summary (registry, in English)
To evaluate the effectiveness and safety of anti-epileptic drugs in the prevention of early and late post-traumatic seizures among patients with trauma brain injury
- Status (registry)
- Not yet recruiting
- Study type
- Observational
- Enrollment
- 70 (estimated)
- First submitted
- 4 Apr 2026
- Start date
- May 2026
- Primary completion date
- May 2027
- Lead sponsor
- Assiut University
- Diseases
- Epilepsy
- NCT number
- NCT07535736
What you commit to
- Study type: Observational
- Planned participants: 70
- From May 2026 to the primary completion date, May 2027
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Prior use of antiepileptic drugs before admission.
Other illness
- Pre-existing epilepsy or seizure disorder.
- Seizure episode before or during admission unrelated to acute TBI.
- Hepatic failure.
- Known hypersensitivity to antiepileptic drugs
Lab values
- Severe renal impairment (creatinine clearance \<30 mL/min).
Other
- Pregnancy or lactation.
Who the study is looking for
- Patients with a confirmed diagnosis of traumatic brain injury (clinical and/or radiological), including both surgical and conservative management
- Admission within 24 hours of injury
- Eligible for antiepileptic prophylaxis according to clinical guidelines
- Written informed consent obtained.
Age in the registry: 18 years to 75 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.